BSV acquires women’s health brand Tidilan EP News Bureau Apr 6, 2022 Tidilan is currently available in tablet and injectable dosage forms
Zeon Lifesciences signs MoU with Delhi Pharma Sciences and Research University EP News Bureau Apr 6, 2022 The MoU aims to accelerate the development of new breakthroughs in the fields of nutraceuticals, phytopharmaceuticals and Ayurveda
Government extends implementation date of track and trace system for export of pharma products EP News Bureau Apr 5, 2022 The date has been extended up to 31st March, 2023
Pharma packaging trends post-COVID-19: The way forward EP News Bureau Apr 5, 2022 Siddharth Shah, Director, Bharat Rubber Works, explains the future trends that the pharma industry might bring into use for…
Intas and Axantia sign licence and supply agreement for Ranibizumab biosimilar in Middle East EP News Bureau Apr 5, 2022 Under the terms of this agreement, Axantia will register, hold the marketing authorisation and commercialise Ranibizumab in…
No increase effected by government in medicine prices: Mansukh Mandaviya Reuters Apr 5, 2022 The government has no role in the price of these medicines, and it has not effected any increase in prices, and it has no plans to…
CanSinoBIO’s mRNA COVID-19 vaccine candidate cleared for clinical trials in China EP News Bureau Apr 5, 2022 Unlike other major countries, China is yet to approve any foreign-made mRNA vaccines such as that produced by American-German duo…
GST rate for COVID-19 medicines pegged at five per cent: Government Press Trust of India Apr 5, 2022 Pankaj Chaudhary, Union Minister of State for Finance, said that 66 per cent of government-sponsored health insurance schemes in…
Mankind Pharma forays into agri-tech industry, launches Mankind Agritech EP News Bureau Apr 5, 2022 The company will invest in the new technological tools, and aims to deliver the same to the farmers to support them
New data for Roche’s Ocrevus show benefit in disability progression and cognitive decline in… EP News Bureau Apr 5, 2022 The treatment with Ocrevus resulted in a majority of patients experiencing no disease progression in a one-year analysis of…